Role of Inflammasome Activation in the Pathophysiology of Vascular Diseases of the Neurovascular Unit

Antioxidants and Redox Signaling

Volumn 22, Issue 13, 2015, Pages 1188-1206

  Mohamed, Islam N ^a,b,c   Ishrat, Tauheed ^a,c   Fagan, Susan C ^a,c   El Remessy, Azza B ^a,b,c  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLAMMASOME; INTERLEUKIN 1BETA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; THIOREDOXIN;

BRAIN ISCHEMIA; HUMAN; INFLAMMATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETINA DISEASE; REVIEW; VASCULAR DISEASE; VASCULARIZATION; ANIMAL; BRAIN; CENTRAL SEROUS RETINOPATHY; DEGENERATIVE DISEASE; METABOLISM; PATHOLOGY; RETINA;

ANIMALS; BRAIN; CENTRAL SEROUS CHORIORETINOPATHY; HUMANS; INFLAMMASOMES; INFLAMMATION; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; RECEPTORS, PATTERN RECOGNITION; RETINA; VASCULAR DISEASES;

EID: 84934765408     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.6126     Document Type: Review

References (165)

1. Abais JM, Xia M, Li G, Gehr TW, Boini KM, and Li PL. Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia. Free Radic Biol Med 67: 211-220, 2014.
2. Abais JM, Zhang C, Xia M, Liu Q, Gehr TW, Boini KM, and Li PL. NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia. Antioxid Redox Signal 18: 1537-1548, 2013.
3. Abdelsaid MA and El-Remessy AB. S-glutathionylation of LMW-PTP regulates VEGF-mediated FAK activation and endothelial cell migration. J Cell Sci 125: 4751-4760, 2012.
4. Abdelsaid MA, Matragoon S, and El-Remessy AB. Thioredoxin-interacting protein expression is required for VEGF-mediated angiogenic signal in endothelial cells. Antioxid Redox Signal 19: 2199-2212, 2013.
5. Abulafia DP, de Rivero Vaccari JP, Lozano JD, Lotocki G, Keane RW, and Dietrich WD. Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. J Cereb Blood Flow Metab 29: 534-544, 2009.
6. Adamczak S, Dale G, de Rivero Vaccari JP, Bullock MR, Dietrich WD, and Keane RW. Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article. J Neurosurg 117: 1119-1125, 2012.
7. Adamis AP and Berman AJ. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol 30: 65-84, 2008.
8. Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, and El-Remessy AB. Neurovascular protective effect of FeTPPs in N-methyl-D-aspartate model: similarities to diabetes. Am J Pathol 177: 1187-1197, 2010.
9. Al-Gayyar MM, Abdelsaid MA, Matragoon S, Pillai BA, and El-Remessy AB. Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity. Br J Pharmacol 164: 170-180, 2011.
10. Anderson OA, Finkelstein A, and Shima DT. A2E induces IL-1ss production in retinal pigment epithelial cells via the NLRP3 inflammasome. PLoS One 8: e67263, 2013.
11. Apelt J and Schliebs R. Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Res 894: 21-30, 2001.
12. Boden G. Interaction between free fatty acids and glucose metabolism. Curr Opin Clin Nutr Metab Care 5: 545-549, 2002.
13. Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 18: 139-143, 2011.
14. Chen GY and Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10: 826-837, 2010.
15. Chen J, Cha-Molstad H, Szabo A, and Shalev A. Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein. Am J Physiol Endocrinol Metab 296: E1133-E1139, 2009.
16. Cheung N and Wong TY. Obesity and eye diseases. Surv Ophthalmol 52: 180-195, 2007.
17. Chung JW, Jeon JH, Yoon SR, and Choi I. Vitamin D3 upregulated protein 1 (VDUP1) is a regulator for redox signaling and stress-mediated diseases. J Dermatol 33: 662-669, 2006.
18. Ciallella JR, Ikonomovic MD, Paljug WR, Wilbur YI, Dixon CE, Kochanek PM, Marion DW, and DeKosky ST. Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats. J Neurotrauma 19: 1555-1567, 2002.
19. Colombo MP and Mantovani A. Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion. Cancer Res 65: 9113-9116, 2005.
20. Courties G, Moskowitz MA, and Nahrendorf M. The innate immune system after ischemic injury: lessons to be learned from the heart and brain. JAMA Neurol 71: 233-236, 2014.
21. Craft JM, Watterson DM, Hirsch E, and Van Eldik LJ. Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human betaamyloid. J Neuroinflammation 2: 15, 2005.
22. Danton GH and Dietrich WD. Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 62: 127-136, 2003.
23. Davis BK, Wen H, and Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 29: 707-735, 2011.
24. de Rivero Vaccari JP, Lotocki G, Alonso OF, Bramlett HM, Dietrich WD, and Keane RW. Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J Cereb Blood Flow Metab 29: 1251-1261, 2009.
25. Demircan N, Safran BG, Soylu M, Ozcan AA, and Sizmaz S. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye (Lond) 20: 1366-1369, 2006.
26. Deroide N, Li X, Lerouet D, Van Vre E, Baker L, Harrison J, Poittevin M, Masters L, Nih L, Margaill I, Iwakura Y, Ryffel B, Pocard M, Tedgui A, Kubis N, and Mallat Z. MFGE8 inhibits inflammasome-induced IL-1beta production and limits postischemic cerebral injury. J Clin Invest 123: 1176-1181, 2013.
27. Devi TS, Lee I, Huttemann M, Kumar A, Nantwi KD, and Singh LP. TXNIP links innate host defense mechanisms to oxidative stress and inflammation in retinal Muller glia under chronic hyperglycemia: implications for diabetic retinopathy. Exp Diabetes Res 2012: 438238, 2012.
28. Dong N, Xu B, Wang B, and Chu L. Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy. Mol Vis 19: 1734-1746, 2013.
29. Dong S, Duan Y, Hu Y, and Zhao Z. Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis. Transl Neurodegener 1: 18, 2012.
30. Dostert C, Guarda G, Romero JF, Menu P, Gross O, Tardivel A, Suva ML, Stehle JC, Kopf M, Stamenkovic I, Corradin G, and Tschopp J. Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS One 4: e6510, 2009.
31. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, and Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357-1361, 2010.
32. Dunn LL, Simpson PJ, Prosser HC, Lecce L, Yuen GS, Buckle A, Sieveking DP, Vanags LZ, Lim PR, Chow RW, Lam YT, Clayton Z, Bao S, Davies MJ, Stadler N, Celermajer DS, Stocker R, Bursill CA, Cooke JP, and Ng MK. A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis. Diabetes 63: 675-687, 2014.
33. Dvoriantchikova G, Ivanov D, Barakat D, Grinberg A, Wen R, Slepak VZ, and Shestopalov VI. Genetic ablation of Pannexin1 protects retinal neurons from ischemic injury. PLoS One 7: e31991, 2012.
34. Eckel RH, Grundy SM, and Zimmet PZ. The metabolic syndrome. Lancet 365: 1415-1428, 2005.
35. El-Azab MF, Baldowski BR, Mysona BA, Shanab AY, Mohamed IN, Abdelsaid MA, Matragoon S, Bollinger KE, Saul A, and El-Remessy AB. Deletion of thioredoxin-interacting protein preserves retinal neuronal function by preventing inflammation and vascular injury. Br J Pharmacol 171: 1299-1313, 2014.
36. Fann DY, Lee SY, Manzanero S, Chunduri P, Sobey CG, and Arumugam TV. Pathogenesis of acute stroke and the role of inflammasomes. Ageing Res Rev 12: 941-966, 2013.
37. Fann DY, Lee SY, Manzanero S, Tang SC, Gelderblom M, Chunduri P, Bernreuther C, Glatzel M, Cheng YL, Thundyil J, Widiapradja A, Lok KZ, Foo SL, Wang YC, Li YI, Drummond GR, Basta M, Magnus T, Jo DG, Mattson MP, Sobey CG, and Arumugam TV. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis 4: e790, 2013.
38. Galliher-Beckley AJ, Lan LQ, Aono S, Wang L, and Shi J. Caspase-1 activation and mature interleukin-1beta release are uncoupled events in monocytes. World J Biol Chem 4: 30-34, 2013.
39. Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, Fernandez-Real JM, and Dandona P. Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, highcarbohydrate meal: implications for insulin resistance. Diabetes Care 32: 2281-2287, 2009.
40. Ghanim H, Sia CL, Korzeniewski K, Lohano T, Abuaysheh S, Marumganti A, Chaudhuri A, and Dandona P. A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab 96: 1409-1414, 2011.
41. Gliem M, Mausberg AK, Lee JI, Simiantonakis I, van Rooijen N, Hartung HP, and Jander S. Macrophages prevent hemorrhagic infarct transformation in murine stroke models. Ann Neurol 71: 743-752, 2012.
42. Gopinath B, Baur LA, Teber E, Liew G, Wong TY, and Mitchell P. Effect of obesity on retinal vascular structure in pre-adolescent children. Int J Pediatr Obes 6: e353-e359, 2011.
43. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschlager N, Endres S, Hartmann G, Tardivel A, Schweighoffer E, Tybulewicz V, Mocsai A, Tschopp J, and Ruland J. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459: 433-436, 2009.
44. Gross O, Thomas CJ, Guarda G, and Tschopp J. The inflammasome: an integrated view. Immunol Rev 243: 136-151, 2011.
45. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, and Golenbock DT. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9: 857-865, 2008.
46. Hang CH, Chen G, Shi JX, Zhang X, and Li JS. Cortical expression of nuclear factor kappaB after human brain contusion. Brain Res 1109: 14-21, 2006.
47. Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, and Golenbock DT. NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493: 674-678, 2013.
48. Hewinson J, Moore SF, Glover C, Watts AG, and MacKenzie AB. A key role for redox signaling in rapid P2X7 receptor-induced IL-1 beta processing in human monocytes. J Immunol 180: 8410-8420, 2008.
49. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, and Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9: 847-856, 2008.
50. Huang C, Lin MZ, Cheng D, Braet F, Pollock CA, and Chen XM. Thioredoxin-interacting protein mediates dysfunction of tubular autophagy in diabetic kidneys through inhibiting autophagic flux. Lab Invest 94: 309-320, 2014.
51. Hutchinson PJ, O'Connell MT, Rothwell NJ, Hopkins SJ, Nortje J, Carpenter KL, Timofeev I, Al-Rawi PG, Menon DK, and Pickard JD. Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra. J Neurotrauma 24: 1545-1557, 2007.
52. Ishrat T, Mohamed IN, Pillai BA, Soliman S, Ergul A, El-Remessy AB, and Fagan SC. Thioredoxin interacting protein: a novel target for neuroprotection in experimental thromboembolic stroke in mice. Mol Neurobiol 2014 [Epub ahead of print]; DOI: 10.1007/s12035-014-8766-x.
53. Iyer SS, He Q, Janczy JR, Elliott EI, Zhong Z, Olivier AK, Sadler JJ, Knepper-Adrian V, Han R, Qiao L, Eisenbarth SC, Nauseef WM, Cassel SL, and Sutterwala FS. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 39: 311-323, 2013.
54. Janeway CA, Jr. Pillars article: approaching the asymptote? Evolution and revolution in immunology. Cold spring harb symp quant biol. 1989. 54: 1-13.
55. J Immunol 191: 4475-4487, 2013.
56. Jedrzejowska-Szypulka H, Larysz-Brysz M, Kukla M, Snietura M, and Lewin-Kowalik J. Neutralization of interleukin-1beta reduces vasospasm and alters cerebral blood vessel density following experimental subarachnoid hemorrhage in rats. Curr Neurovasc Res 6: 95-103, 2009.
57. Jha S, Srivastava SY, Brickey WJ, Iocca H, Toews A, Morrison JP, Chen VS, Gris D, Matsushima GK, and Ting JP. The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J Neurosci 30: 15811-15820, 2010.
58. Jin C and Flavell RA. Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol 30: 628-631, 2010.
59. Junn E, Han SH, Im JY, Yang Y, Cho EW, Um HD, Kim DK, Lee KW, Han PL, Rhee SG, and Choi I. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol 164: 6287-6295, 2000.
60. Karpe F, Dickmann JR, and Frayn KN. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes 60: 2441-2449, 2011.
61. Kawasaki R, Tielsch JM, Wang JJ, Wong TY, Mitchell P, Tano Y, Tominaga M, Oizumi T, Daimon M, Kato T, Kawata S, Kayama T, and Yamashita H. The metabolic syndrome and retinal microvascular signs in a Japanese population: the Funagata study. Br J Ophthalmol 92: 161-166, 2008.
62. Kerur N, Hirano Y, Tarallo V, Fowler BJ, Bastos-Carvalho A, Yasuma T, Yasuma R, Kim Y, Hinton DR, Kirschning CJ, Gelfand BD, and Ambati J. TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy. Invest Ophthalmol Vis Sci 54: 7395-7401, 2013.
63. Kim SJ and Lee SM. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1. Free Radic Biol Med 65: 997-1004, 2013.
64. Kinoshita K, Chatzipanteli iK, Vitarbo E, Truettner JS, Alonso OF, and Dietrich WD. Interleukin-1beta messenger ribonucleic acid and protein levels after fluid-percussion brain injury in rats: importance of injury severity and brain temperature. Neurosurgery 51: 195-203; discussion 203, 2002.
65. Klein R, Myers CE, Lee KE, and Klein BE. 15-year cumulative incidence and associated risk factors for retinopathy in nondiabetic persons. Arch Ophthalmol 128: 1568-1575, 2010.
66. Knopp RH, Retzlaff B, Walden C, Fish B, Buck B, and McCann B. One-year effects of increasingly fat-restricted, carbohydrate-enriched diets on lipoprotein levels in freeliving subjects. Proc Soc Exp Biol Med 225: 191-199, 2000.
67. Koenen TB, Stienstra R, van Tits LJ, de Graaf J, Stalenhoef AF, Joosten LA, Tack CJ, and Netea MG. Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue. Diabetes 60: 517-524, 2011.
68. Koleva-Georgieva DN, Sivkova NP, and Terzieva D. Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy. Folia Med (Plovdiv) 53: 44-50, 2011.
69. Kono H, Onda A, and Yanagida T. Molecular determinants of sterile inflammation. Curr Opin Immunol 26: 147-156, 2014.
70. Kowluru RA and Odenbach S. Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. Invest Ophthalmol Vis Sci 45: 4161-4166, 2004.
71. Kowluru RA and Odenbach S. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol 88: 1343-1347, 2004.
72. Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, and Levison SW. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54: 1559-1565, 2005.
73. Krizaj D, Ryskamp DA, Tian N, Tezel G, Mitchell CH, Slepak VZ, and Shestopalov VI. From mechanosensitivity to inflammatory responses: new players in the pathology of glaucoma. Curr Eye Res 39: 105-119, 2014.
74. Krogmann A, Staiger K, Haas C, Gommer N, Peter A, Heni M, Machicao F, Haring HU, and Staiger H. Inflammatory response of human coronary artery endothelial cells to saturated long-chain fatty acids. Microvasc Res 81: 52-59, 2011.
75. Lamkanfi M and Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 28: 137-161, 2012.
76. Lane T, Flam B, Lockey R, and Kolliputi N. TXNIP shuttling: missing link between oxidative stress and inflammasome activation. Front Physiol 4: 50, 2013.
77. Lerner AG, Upton JP, Praveen PV, Ghosh R, Nakagawa Y, Igbaria A, Shen S, Nguyen V, Backes BJ, Heiman M, Heintz N, Greengard P, Hui S, Tang Q, Trusina A, Oakes SA, and Papa FR. IRE1alpha induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab 16: 250-264, 2012.
78. Liu HD, Li W, Chen ZR, Hu YC, Zhang DD, Shen W, Zhou ML, Zhu L, and Hang CH. Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model. Neurochem Res 38: 2072-2083, 2013.
79. Liu L and Chan C. The role of inflammasome in Alzheimer's disease. Ageing Res Rev 15C: 6-15, 2014.
80. Liu RT, Gao J, Cao S, Sandhu N, Cui JZ, Chou CL, Fang E, and Matsubara JA. Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration. Invest Ophthalmol Vis Sci 54: 2225-2237, 2013.
81. Liu Y, Biarnes Costa M, and Gerhardinger C. IL-1beta is upregulated in the diabetic retina and retinal vessels: cellspecific effect of high glucose and IL-1beta autostimulation. PLoS One 7: e36949, 2012.
82. Lue LF, Rydel R, Brigham EF, Yang LB, Hampel H, Murphy GM, Jr., Brachova L, Yan SD, Walker DG, Shen Y, and Rogers J. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 35: 72-79, 2001.
83. Luheshi NM, Kovacs KJ, Lopez-Castejon G, Brough D, and Denes A. Interleukin-1alpha expression precedes IL-1beta after ischemic brain injury and is localised to areas of focal neuronal loss and penumbral tissues. J Neuroinflammation 8: 186, 2011.
84. Lunov O, Syrovets T, Loos C, Nienhaus GU, Mailander V, Landfester K, Rouis M, and Simmet T. Amino-functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages. ACS Nano 5: 9648-9657, 2011.
85. Luo B, Li B, Wang W, Liu X, Xia Y, Zhang C, Zhang Y, Zhang M, and An F. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model. Cardiovasc Drugs Ther 28: 33-43, 2014.
86. Mahmood DF, Abderrazak A, El Hadri K, Simmet T, and Rouis M. The thioredoxin system as a therapeutic target in human health and disease. Antioxid Redox Signal 19: 1266-1303, 2013.
87. Martinon F. Signaling by ROS drives inflammasome activation. Eur J Immunol 40: 616-619, 2010.
88. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, Mullooly N, Mielke LA, Harris J, Coll RC, Mills KH, Mok KH, Newsholme P, Nunez G, Yodoi J, Kahn SE, Lavelle EC, and O'Neill LA. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 11: 897-904, 2010.
89. Mastronardi C, Whelan F, Yildiz OA, Hannestad J, Elashoff D, McCann SM, Licinio J, and Wong ML. Caspase 1 deficiency reduces inflammation-induced brain transcription. Proc Natl Acad Sci U S A 104: 7205-7210, 2007.
90. Masutani H, Yoshihara E, Masaki S, Chen Z, and Yodoi J. Thioredoxin binding protein (TBP)-2/Txnip and alphaarrestin proteins in cancer and diabetes mellitus. J Clin Biochem Nutr 50: 23-34, 2012.
91. Matsuzaka T, Atsumi A, Matsumori R, Nie T, Shinozaki H, Suzuki-Kemuriyama N, Kuba M, Nakagawa Y, Ishii K, Shimada M, Kobayashi K, Yatoh S, Takahashi A, Takekoshi K, Sone H, Yahagi N, Suzuki H, Murata S, Nakamuta M, Yamada N, and Shimano H. Elovl6 promotes nonalcoholic steatohepatitis. Hepatology 56: 2199-2208, 2012.
92. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 12: 991-1045, 1994.
93. McColl BW, Allan SM, and Rothwell NJ. Systemic infection, inflammation and acute ischemic stroke. Neuroscience 158: 1049-1061, 2009.
94. Medzhitov R. Origin and physiological roles of inflammation. Nature 454: 428-435, 2008.
95. Menu P, Mayor A, Zhou R, Tardivel A, Ichijo H, Mori K, and Tschopp J. ER stress activates the NLRP3 inflammasome via an UPR-independent pathway. Cell Death Dis 3: e261, 2012.
96. Meyer Y, Buchanan BB, Vignols F, and Reichheld JP. Thioredoxins and glutaredoxins: unifying elements in redox biology. Annu Rev Genet 43: 335-367, 2009.
97. Misawa T, Takahama M, Kozaki T, Lee H, Zou J, Saitoh T, and Akira S. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol 14: 454-460, 2013.
98. Mohamed IN, Hafez SS, Fairaq A, Ergul A, Imig JD, and El-Remessy AB. Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet. Diabetologia 57: 413-423, 2014.
99. Mohr S, Xi X, Tang J, and Kern TS. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 51: 1172-1179, 2002.
100. Moore SF and MacKenzie AB. NADPH oxidase NOX2 mediates rapid cellular oxidation following ATP stimulation of endotoxin-primed macrophages. J Immunol 183: 3302-3308, 2009.
101. Mora S and Ridker PM. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)-can C-reactive protein be used to target statin therapy in primary prevention? Am J Cardiol 97: 33A-41A, 2006.
102. Murakami T, Ockinger J, Yu J, Byles V, McColl A, Hofer AM, and Horng T. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci U S A 109: 11282-11287, 2012.
103. Murphy N, Grehan B, and Lynch MA. Glial uptake of amyloid beta induces NLRP3 inflammasome formation via cathepsin-dependent degradation of NLRP10. Neuromolecular Med 16: 205-215, 2014.
104. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, and Pittet MJ. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 204: 3037-3047, 2007.
105. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim HP, Fitzgerald KA, Ryter SW, and Choi AM. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12: 222-230, 2011.
106. Nguyen TT and Wong TY. Retinal vascular manifestations of metabolic disorders. Trends Endocrinol Metab 17: 262-268, 2006.
107. Nilupul Perera M, Ma HK, Arakawa S, Howells DW, Markus R, Rowe CC, and Donnan GA. Inflammation following stroke. J Clin Neurosci 13: 1-8, 2006.
108. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, and Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274: 21645-21650, 1999.
109. Ojala J, Alafuzoff I, Herukka SK, van Groen T, Tanila H, and Pirttila T. Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients. Neurobiol Aging 30: 198-209, 2009.
110. Oslowski CM, Hara T, O'Sullivan-Murphy B, Kanekura K, Lu S, Hara M, Ishigaki S, Zhu LJ, Hayashi E, Hui ST, Greiner D, Kaufman RJ, Bortell R, and Urano F. Thioredoxin-interacting protein mediates ER stress-induced beta cell death through initiation of the inflammasome. Cell Metab 16: 265-273, 2012.
111. Park SY, Shi X, Pang J, Yan C, and Berk BC. Thioredoxin-interacting protein mediates sustained VEGFR2 signaling in endothelial cells required for angiogenesis. Arterioscler Thromb Vasc Biol 33: 737-743, 2013.
112. Park YJ, Yoon SJ, Suh HW, Kim DO, Park JR, Jung H, Kim TD, Yoon SR, Min JK, Na HJ, Lee SJ, Lee HG, Lee YH, Lee HB, and Choi I. TXNIP deficiency exacerbates endotoxic shock via the induction of excessive nitric oxide synthesis. PLoS Pathog 9: e1003646, 2013.
113. Patwari P, Higgins LJ, Chutkow WA, Yoshioka J, and Lee RT. The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem 281: 21884-21891, 2006.
114. Pejnovic NN, Pantic JM, Jovanovic IP, Radosavljevic GD, Milovanovic MZ, Nikolic IG, Zdravkovic NS, Djukic AL, Arsenijevic NN, and Lukic ML. Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets. Diabetes 62: 1932-1944, 2013.
115. Perrone L, Devi TS, Hosoya K, Terasaki T, and Singh LP. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J Cell Physiol 221: 262-272, 2009.
116. Perrone L, Devi TS, Hosoya KI, Terasaki T, and Singh LP. Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy. Cell Death Dis 1: e65, 2010.
117. Polekhina G, Ascher DB, Kok SF, and Waltham M. Crystallization and preliminary X-ray analysis of the Nterminal domain of human thioredoxin-interacting protein. Acta Crystallogr Sect F Struct Biol Cryst Commun 67: 613-617, 2011.
118. Rivera JC, Sitaras N, Noueihed B, Hamel D, Madaan A, Zhou T, Honore JC, Quiniou C, Joyal JS, Hardy P, Sennlaub F, Lubell W, and Chemtob S. Microglia and interleukin-1beta in ischemic retinopathy elicit microvascular degeneration through neuronal semaphorin-3A. Arterioscler Thromb Vasc Biol 33: 1881-1891, 2013.
119. Rubartelli A, Lotze MT, Latz E, and Manfredi A. Mechanisms of sterile inflammation. Front Immunol 4: 398, 2013.
120. Sastre M, Walter J, and Gentleman SM. Interactions between APP secretases and inflammatory mediators. J Neuroinflammation 5: 25, 2008.
121. Savage CD, Lopez-Castejon G, Denes A, and Brough D. NLRP3-inflammasome activating damps stimulate an inflammatory response in glia in the absence of priming which contributes to brain inflammation after injury. Front Immunol 3: 288, 2012.
122. Saxena G, Chen J, and Shalev A. Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein. J Biol Chem 285: 3997-4005, 2010.
123. Schiffrin EL. Immune mechanisms in hypertension and vascular injury. Clin Sci (Lond) 126: 267-274, 2014.
124. Schmidt KG, Bergert H, and Funk RH. Neurodegenerative diseases of the retina and potential for protection and recovery. Curr Neuropharmacol 6: 164-178, 2008.
125. Schroder K, Zhou R, and Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger? Science 327: 296-300, 2010.
126. Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG, and Wallace JL. Resolution of inflammation: state of the art, definitions and terms. FASEB J 21: 325-332, 2007.
127. Shi JQ, Zhang CC, Sun XL, Cheng XX, Wang JB, Zhang YD, Xu J, and Zou HQ. Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe/PS1dE9 transgenic mice via inhibition of nuclear factor-kappaB and NLRP3 inflammasome activation. CNS Neurosci Ther 19: 262-268, 2013.
128. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, Rentsendorj A, Vargas M, Guerrero C, Wang Y, Fitzgerald KA, Underhill DM, Town T, and Arditi M. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36: 401-414, 2012.
129. Singh LP. Thioredoxin interacting protein (TXNIP) and pathogenesis of diabetic retinopathy. J Clin Exp Ophthalmol 4, 2013.
130. Spindel ON, World C, and Berk BC. Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms. Antioxid Redox Signal 16: 587-596, 2012.
131. Staiger H, Staiger K, Stefan N, Wahl HG, Machicao F, Kellerer M, and Haring HU. Palmitate-induced interleukin-6 expression in human coronary artery endothelial cells. Diabetes 53: 3209-3216, 2004.
132. Stienstra R, Joosten LA, Koenen T, van Tits B, van Diepen JA, van den Berg SA, Rensen PC, Voshol PJ, Fantuzzi G, Hijmans A, Kersten S, Muller M, van den Berg WB, van Rooijen N, Wabitsch M, Kullberg BJ, van der Meer JW, Kanneganti T, Tack CJ, and Netea MG. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab 12: 593-605, 2010.
133. Strowig T, Henao-Mejia J, Elinav E, and Flavell R. Inflammasomes in health and disease. Nature 481: 278-286, 2012.
134. Subramanian N, Natarajan K, Clatworthy MR, Wang Z, and Germain RN. The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell 153: 348-361, 2013.
135. Suresh R and Mosser DM. Pattern recognition receptors in innate immunity, host defense, and immunopathology. Adv Physiol Educ 37: 284-291, 2013.
136. Sutterwala FS, Haasken S, and Cassel SL. Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci 1319: 82-95, 2014.
137. Takeuchi O and Akira S. Pattern recognition receptors and inflammation. Cell 140: 805-820, 2010.
138. Tamaoka A. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"]. Rinsho Byori 61: 1060-1069, 2013.
139. Tang D, Kang R, Coyne CB, Zeh HJ, and Lotze MT. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev 249: 158-175, 2012.
140. Tarallo V, Hirano Y, Gelfand BD, Dridi S, Kerur N, Kim Y, Cho WG, Kaneko H, Fowler BJ, Bogdanovich S, Albuquerque RJ, Hauswirth WW, Chiodo VA, Kugel JF, Goodrich JA, Ponicsan SL, Chaudhuri G, Murphy MP, Dunaief JL, Ambati BK, Ogura Y, Yoo JW, Lee DK, Provost P, Hinton DR, Nunez G, Baffi JZ, Kleinman ME, and Ambati J. DICER1 loss and Alu RNA induce agerelated macular degeneration via the NLRP3 inflammasome and MyD88. Cell 149: 847-859, 2012.
141. Tezel G, Yang X, Luo C, Cai J, and Powell DW. An astrocyte-specific proteomic approach to inflammatory responses in experimental rat glaucoma. Invest Ophthalmol Vis Sci 53: 4220-4233, 2012.
142. Tomura S, de Rivero Vaccari JP, Keane RW, Bramlett HM, and Dietrich WD. Effects of therapeutic hypothermia on inflammasome signaling after traumatic brain injury. J Cereb Blood Flow Metab 32: 1939-1947, 2012.
143. Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A, and Dandona P. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes 52: 2882-2887, 2003.
144. Trueblood KE, Mohr S, and Dubyak GR. Purinergic regulation of high-glucose-induced caspase-1 activation in the rat retinal Muller cell line rMC-1. Am J Physiol Cell Physiol 301: C1213-C1223, 2011.
145. Tseng WA, Thein T, Kinnunen K, Lashkari K, Gregory MS, D'Amore PA, and Ksander BR. NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration. Invest Ophthalmol Vis Sci 54: 110-120, 2013.
146. Tsuchiya K and Hara H. The inflammasome and its regulation. Crit Rev Immunol 34: 41-80, 2014.
147. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, and Polak BC. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 121: 245-251, 2003.
148. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, and Dixit VD. The NLRP3 inflammasome instigates obesityinduced inflammation and insulin resistance. Nat Med 17: 179-188, 2011.
149. Vincent JA and Mohr S. Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes 56: 224-230, 2007.
150. Wang W, Wang C, Ding XQ, Pan Y, Gu TT, Wang MX, Liu YL, Wang FM, Wang SJ, and Kong LD. Quercetin and allopurinol reduce liver thioredoxin-interacting protein to alleviate inflammation and lipid accumulation in diabetic rats. Br J Pharmacol 169: 1352-1371, 2013.
151. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ, and Ting JP. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12: 408-415, 2011.
152. Wen H, Miao EA, and Ting JP. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 39: 432-441, 2013.
153. Whitmire W, Al-Gayyar MM, Abdelsaid M, Yousufzai BK, and El-Remessy AB. Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far. Mol Vis 17: 300-308, 2011.
154. Wong TY, Duncan BB, Golden SH, Klein R, Couper DJ, Klein BE, Hubbard LD, Sharrett AR, and Schmidt MI. Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk in Communities study. Invest Ophthalmol Vis Sci 45: 2949-2954, 2004.
155. World C, Spindel ON, and Berk BC. Thioredoxin-interacting protein mediates TRX1 translocation to the plasma membrane in response to tumor necrosis factor-alpha: a key mechanism for vascular endothelial growth factor receptor-2 transactivation by reactive oxygen species. Arterioscler Thromb Vasc Biol 31: 1890-1897, 2011.
156. Wu N, Zheng B, Shaywitz A, Dagon Y, Tower C, Bellinger G, Shen CH, Wen J, Asara J, McGraw TE, Kahn BB, and Cantley LC. AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol Cell 49: 1167-1175, 2013.
157. Xiang M, Shi X, Li Y, Xu J, Yin L, Xiao G, Scott MJ, Billiar TR, Wilson MA, and Fan J. Hemorrhagic shock activation of NLRP3 inflammasome in lung endothelial cells. J Immunol 187: 4809-4817, 2011.
158. Yamawaki H, Pan S, Lee RT, and Berk BC. Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J Clin Invest 115: 733-738, 2005.
159. Yang F, Wang Z, Wei X, Han H, Meng X, Zhang Y, Shi W, Li F, Xin T, Pang Q, and Yi F. NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke. J Cereb Blood Flow Metab 34: 660, 2014.
160. Yego EC, Vincent JA, Sarthy V, Busik JV, and Mohr S. Differential regulation of high glucose-induced glyceraldehyde-3-phosphate dehydrogenase nuclear accumulation in Muller cells by IL-1beta and IL-6. Invest Ophthalmol Vis Sci 50: 1920-1928, 2009.
161. Yilmaz G and Granger DN. Cell adhesion molecules and ischemic stroke. Neurol Res 30: 783-793, 2008.
162. Zhang QY, Pan Y, Wang R, Kang LL, Xue QC, Wang XN, and Kong LD. Quercetin inhibits AMPK/TXNIP activation and reduces inflammatory lesions to improve insulin signaling defect in the hypothalamus of high fructose-fed rats. J Nutr Biochem 25: 420-428, 2014.
163. Zhao JB, Zhang Y, Li GZ, Su XF, and Hang CH. Activation of JAK2/STAT pathway in cerebral cortex after experimental traumatic brain injury of rats. Neurosci Lett 498: 147-152, 2011.
164. Zhou R, Tardivel A, Thorens B, Choi I, and Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11: 136-140, 2010.
165. Zhou R, Yazdi AS, Menu P, and Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221-225, 2011.